• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

为评估肝脂肪变性,我们应该重复测量超声引导下衰减参数多少次?

How many times should we repeat measurements of the ultrasound-guided attenuation parameter for evaluating hepatic steatosis?

作者信息

Seo Duck Min, Lee Sang Min, Park Ji Won, Kim Min-Jeong, Ha Hong Il, Park Sun-Young, Lee Kwanseop

机构信息

Department of Radiology, Hallym University Sacred Heart Hospital, Anyang, Korea.

Department of Radiology, CHA University Gangnam Medical Center, Seoul, Korea.

出版信息

Ultrasonography. 2023 Apr;42(2):227-237. doi: 10.14366/usg.22122. Epub 2022 Oct 31.

DOI:10.14366/usg.22122
PMID:36935602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10071056/
Abstract

PURPOSE

This retrospective study aimed to determine the number of times the ultrasound-guided attenuation parameter (UGAP) should be measured during the evaluation of hepatic steatosis.

METHODS

Patients with suspected nonalcoholic fatty liver disease who underwent two UGAP repetition protocols (six-repetition [UGAP_6] and 12-repetition [UGAP_12]) and measurement of the controlled attenuation parameter (CAP) using transient elastography between October 2020 and June 2021 were enrolled. The mean attenuation coefficient (AC), interquartile range (IQR)/median, and coefficient of variance (CV) of the two repetition protocols were compared using the paired t test. Moreover, the diagnostic performances of UGAP_6 and UGAP_12 were compared using the area under the receiver operating characteristic (AUROC) curve, considering the CAP value as a reference standard.

RESULTS

The study included 160 patients (100 men; mean age, 50.9 years). There were no significant differences between UGAP_6 and UGAP_12 (0.731±0.116 dB/cm/MHz vs. 0.734±0.113 dB/cm/MHz, P=0.156) and mean CV (7.6±0.3% vs. 8.0±0.3%, P=0.062). However, the mean IQR/median of UGAP_6 was significantly lower than that of UGAP_12 (8.9%±6.0% vs. 9.8%±5.2%, P=0.012). In diagnosing the hepatic steatosis stage, UGAP_6 and UGAP_12 yielded comparable AUROCs (≥S1, 0.908 vs. 0.897, P=0.466; ≥S2, 0.883 vs. 0.897, P=0.126; S3, 0.832 vs. 0.834, P=0.799).

CONCLUSION

UGAP had high diagnostic performance in diagnosing hepatic steatosis, regardless of the number of repetitions (six repetitions vs. 12 repetitions), with maintained reliability. Therefore, six UGAP measurements seem sufficient for evaluating hepatic steatosis using UGAP.

摘要

目的

本回顾性研究旨在确定在评估肝脂肪变性过程中超声引导下衰减参数(UGAP)的测量次数。

方法

纳入2020年10月至2021年6月期间接受两种UGAP重复方案(六次重复[UGAP_6]和十二次重复[UGAP_12])并使用瞬时弹性成像测量受控衰减参数(CAP)的疑似非酒精性脂肪性肝病患者。使用配对t检验比较两种重复方案的平均衰减系数(AC)、四分位数间距(IQR)/中位数和变异系数(CV)。此外,以CAP值作为参考标准,使用受试者操作特征曲线下面积(AUROC)比较UGAP_6和UGAP_12的诊断性能。

结果

该研究纳入了160例患者(100名男性;平均年龄50.9岁)。UGAP_6和UGAP_12之间的AC无显著差异(0.731±0.116 dB/cm/MHz对0.734±0.113 dB/cm/MHz,P = 0.156),平均CV也无显著差异(7.6±0.3%对8.0±0.3%,P = 0.062)。然而,UGAP_6的平均IQR/中位数显著低于UGAP_12(8.9%±6.0%对9.8%±5.2%,P = 0.012)。在诊断肝脂肪变性阶段时,UGAP_6和UGAP_12产生了相当的AUROC(≥S1,0.908对0.897,P = 0.466;≥S2,0.883对0.897,P = 0.126;S3,0.832对0.834,P = 0.799)。

结论

无论重复次数(六次重复对十二次重复)如何,UGAP在诊断肝脂肪变性方面具有较高的诊断性能,且可靠性保持不变。因此,对于使用UGAP评估肝脂肪变性而言,六次UGAP测量似乎就足够了。

相似文献

1
How many times should we repeat measurements of the ultrasound-guided attenuation parameter for evaluating hepatic steatosis?为评估肝脂肪变性,我们应该重复测量超声引导下衰减参数多少次?
Ultrasonography. 2023 Apr;42(2):227-237. doi: 10.14366/usg.22122. Epub 2022 Oct 31.
2
Diagnostic accuracy of ultrasound-guided attenuation parameter as a noninvasive test for steatosis in non-alcoholic fatty liver disease.超声引导衰减参数作为非酒精性脂肪性肝病肝脂肪变的无创性检测的诊断准确性。
J Med Ultrason (2001). 2021 Oct;48(4):471-480. doi: 10.1007/s10396-021-01123-0. Epub 2021 Aug 20.
3
The ultrasound-guided attenuation parameter is useful in quantification of hepatic steatosis in non-alcoholic fatty liver disease.超声引导下的衰减参数在非酒精性脂肪性肝病肝脂肪变性的量化评估中很有用。
JGH Open. 2021 Jul 16;5(8):947-952. doi: 10.1002/jgh3.12615. eCollection 2021 Aug.
4
Correlation and Performance of three Ultrasound Techniques to Stage Hepatic Steatosis in Nonalcoholic Fatty Liver Disease.三种超声技术对非酒精性脂肪性肝病肝脂肪变分期的相关性及效能比较。
Curr Med Imaging. 2024;20:1-12. doi: 10.2174/0115734056278434231213112035.
5
Performance of ultrasound-guided attenuation parameter and 2D shear wave elastography in patients with metabolic dysfunction-associated steatotic liver disease.超声引导下衰减参数和二维剪切波弹性成像在代谢功能障碍相关脂肪性肝病患者中的应用
Eur Radiol. 2025 Apr;35(4):2339-2350. doi: 10.1007/s00330-024-11076-w. Epub 2024 Oct 7.
6
Ultrasound-Guided Attenuation Parameter (UGAP) for the quantification of liver steatosis using the Controlled Attenuation Parameter (CAP) as the reference method.超声引导衰减参数(UGAP)用于定量肝脂肪变性,以受控衰减参数(CAP)作为参考方法。
Med Ultrason. 2021 Feb 18;23(1):7-14. doi: 10.11152/mu-2688. Epub 2020 Oct 8.
7
The B-Mode Image-Guided Ultrasound Attenuation Parameter Accurately Detects Hepatic Steatosis in Chronic Liver Disease.B 型图像引导超声衰减参数可准确检测慢性肝病中的肝脂肪变性。
Ultrasound Med Biol. 2018 Nov;44(11):2223-2232. doi: 10.1016/j.ultrasmedbio.2018.06.017. Epub 2018 Aug 2.
8
Diagnostic performance of a novel ultrasound-based quantitative method to assess liver steatosis in histologically identified nonalcoholic fatty liver disease.一种基于超声的新型定量方法在组织学确诊的非酒精性脂肪性肝病中评估肝脏脂肪变性的诊断性能。
Med Ultrason. 2023 Mar 30;25(1):7-13. doi: 10.11152/mu-3815. Epub 2023 Feb 7.
9
Clinical Utility of Ultrasound-Guided Attenuation Parameter for the Detection and Quantification of Hepatic Steatosis in Patients with Fatty Liver Diagnosed by Computed Tomography.超声引导下衰减参数在计算机断层扫描诊断的脂肪肝患者肝脂肪变性检测及定量中的临床应用
Ultrasound Med Biol. 2022 Jul;48(7):1282-1289. doi: 10.1016/j.ultrasmedbio.2022.02.023. Epub 2022 Apr 6.
10
Utility of Ultrasound-Guided Attenuation Parameter for Grading Steatosis With Reference to MRI-PDFF in a Large Cohort.超声引导衰减参数在大样本中的 MRI-PDFF 对脂肪变性分级的效用。
Clin Gastroenterol Hepatol. 2022 Nov;20(11):2533-2541.e7. doi: 10.1016/j.cgh.2021.11.003. Epub 2021 Nov 10.

引用本文的文献

1
Ultrasound-guided attenuation parameter for identifying metabolic dysfunction-associated steatotic liver disease: a prospective study.超声引导下衰减参数用于识别代谢功能障碍相关脂肪性肝病:一项前瞻性研究。
Ultrasonography. 2025 Mar;44(2):134-144. doi: 10.14366/usg.24204. Epub 2024 Dec 19.
2
Performance of ultrasound-guided attenuation parameter and 2D shear wave elastography in patients with metabolic dysfunction-associated steatotic liver disease.超声引导下衰减参数和二维剪切波弹性成像在代谢功能障碍相关脂肪性肝病患者中的应用
Eur Radiol. 2025 Apr;35(4):2339-2350. doi: 10.1007/s00330-024-11076-w. Epub 2024 Oct 7.
3

本文引用的文献

1
Simplification of 2D shear wave elastography by enlarged SWE box and multiple regions of interest in one acquisition.二维剪切波弹性成像通过增大 SWE 框和在一次采集中使用多个感兴趣区进行简化。
PLoS One. 2022 Sep 9;17(9):e0273769. doi: 10.1371/journal.pone.0273769. eCollection 2022.
2
Reproducibility of ultrasound-guided attenuation parameter (UGAP) to the noninvasive evaluation of hepatic steatosis.超声引导衰减参数(UGAP)在无创性评估肝脂肪变性中的可重复性。
Sci Rep. 2022 Feb 21;12(1):2876. doi: 10.1038/s41598-022-06879-0.
3
Assessment of the inter-platform reproducibility of ultrasound attenuation examination in nonalcoholic fatty liver disease.
Impact of Respiratory Motion on the Quantification of Pediatric Hepatic Steatosis Using Two Different Ultrasonography Machines.
两种不同超声设备检测儿童肝脂肪变时呼吸运动的影响。
Yonsei Med J. 2024 Oct;65(10):602-610. doi: 10.3349/ymj.2023.0440.
4
Advanced fibrosis leads to overestimation of steatosis with quantitative ultrasound in individuals without hepatic steatosis.在没有肝脂肪变性的个体中,晚期肝纤维化会导致定量超声对脂肪变性的高估。
Ultrasonography. 2024 Mar;43(2):121-131. doi: 10.14366/usg.23194. Epub 2023 Dec 11.
非酒精性脂肪性肝病超声衰减检查的跨平台可重复性评估。
Ultrasonography. 2022 Apr;41(2):355-364. doi: 10.14366/usg.21167. Epub 2021 Oct 31.
4
Utility of Ultrasound-Guided Attenuation Parameter for Grading Steatosis With Reference to MRI-PDFF in a Large Cohort.超声引导衰减参数在大样本中的 MRI-PDFF 对脂肪变性分级的效用。
Clin Gastroenterol Hepatol. 2022 Nov;20(11):2533-2541.e7. doi: 10.1016/j.cgh.2021.11.003. Epub 2021 Nov 10.
5
Diagnostic Performance of 2-D Shear Wave Elastography on the Evaluation of Hepatic Fibrosis with Emphasis on Impact of the Different Region-of-Interest Methods.二维剪切波弹性成像技术评估肝纤维化的诊断性能:重点探讨不同感兴趣区方法的影响
Ultrasound Med Biol. 2022 Feb;48(2):198-208. doi: 10.1016/j.ultrasmedbio.2021.09.020. Epub 2021 Oct 27.
6
MAFLD enhances clinical practice for liver disease in the Asia-Pacific region.MAFLD改善了亚太地区肝脏疾病的临床实践。
Clin Mol Hepatol. 2022 Apr;28(2):150-163. doi: 10.3350/cmh.2021.0310. Epub 2021 Nov 10.
7
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease.KASL临床实践指南:非酒精性脂肪性肝病的管理
Clin Mol Hepatol. 2021 Jul;27(3):363-401. doi: 10.3350/cmh.2021.0178. Epub 2021 Jun 22.
8
Quantitative assessment of liver steatosis using ultrasound controlled attenuation parameter (Echosens).使用超声控制衰减参数(Echosens)定量评估肝脏脂肪变性。
J Med Ultrason (2001). 2021 Oct;48(4):489-495. doi: 10.1007/s10396-021-01106-1. Epub 2021 Jun 16.
9
Quantitative Ultrasound Radiofrequency Data Analysis for the Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Using Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard.磁共振成像质子密度脂肪分数作为参考标准的非酒精性脂肪性肝病肝脂肪变性的定量超声射频数据分析。
Korean J Radiol. 2021 Jul;22(7):1077-1086. doi: 10.3348/kjr.2020.1262. Epub 2021 Mar 9.
10
Ultrasound-Guided Attenuation Parameter (UGAP) for the quantification of liver steatosis using the Controlled Attenuation Parameter (CAP) as the reference method.超声引导衰减参数(UGAP)用于定量肝脂肪变性,以受控衰减参数(CAP)作为参考方法。
Med Ultrason. 2021 Feb 18;23(1):7-14. doi: 10.11152/mu-2688. Epub 2020 Oct 8.